➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Patent: 10,105,415

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,105,415

Title:	Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
Abstract:	The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and fosfomycin for the treatment, prevention or alleviation of an inflammatory bowel disease such as Crohn\'s disease, ulcerative colitis or necrotizing enterocolitis of newborn and premature infants by administration of the compositions into the intestinal lumen.
Inventor(s):	Heslet; Lars (Gentofte, DK), Uttenthal; Lars Otto (Salamanca, ES)
Assignee:	Reponex Pharmaceuticals A/S (Horsholm, DK)
Application Number:	15/328,426
Patent Claims:	see list of patent claims

Details for Patent 10,105,415

Glossary

Subscribe to access the full database, or Free Forever Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Bayer Hlthcare	TRASYLOL	aprotinin	INJECTABLE;INJECTION	020304	001	1994-02-07	⤷ Free Forever Trial	Reponex Pharmaceuticals A/S (Horsholm, DK)	2034-07-24	DISCN		search
Berlex Labs	LEUKINE	sargramostim	VIAL	103362	001	1991-03-05	⤷ Free Forever Trial	Reponex Pharmaceuticals A/S (Horsholm, DK)	2034-07-24	RX		search
Berlex Labs	LEUKINE	sargramostim	VIAL	103362	002	1991-03-05	⤷ Free Forever Trial	Reponex Pharmaceuticals A/S (Horsholm, DK)	2034-07-24	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,105,415

Subscribe to access the full database, or Free Forever Trial
Country	Patent Number	Estimated Expiration
European Patent Office	3171887	⤷ Free Forever Trial
United States of America	2017196937	⤷ Free Forever Trial
World Intellectual Property Organization (WIPO)	2016012608	⤷ Free Forever Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.